---
title: "What Does the Market Think About GlycoMimetics?"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/243526019.md"
description: "GlycoMimetics's GLYC short percent of float has fallen 8.14% since its last report. The company recently reported that it has 1.68 million shares sold short, which is 3.16% of all regular shares that are available for trading."
datetime: "2025-06-06T17:33:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/243526019.md)
  - [en](https://longbridge.com/en/news/243526019.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/243526019.md)
---

# What Does the Market Think About GlycoMimetics?

GlycoMimetics's GLYC short percent of float has fallen 8.14% since its last report. The company recently reported that it has 1.68 million shares sold short, which is 3.16% of all regular shares that are available for trading.

### Related Stocks

- [GLYC.US](https://longbridge.com/en/quote/GLYC.US.md)
- [CBIO.US](https://longbridge.com/en/quote/CBIO.US.md)

## Related News & Research

- [Crescita Narrows Losses in 2025 and Agrees to Premium All-Cash Takeover by ClinActiv](https://longbridge.com/en/news/281224300.md)
- [Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement](https://longbridge.com/en/news/281179927.md)
- [10:08 ETCellipont Bioservices and BobcatBio Announce Strategic Collaboration to Advance Macrophage Cell Therapy for Solid Tumors](https://longbridge.com/en/news/279448474.md)
- [Crescent Biopharma Grants Stock Options to New Employees Under Inducement Plan](https://longbridge.com/en/news/274356235.md)
- [BUZZ-Guggenheim initiates coverage on Crescent Biopharma with 'buy'](https://longbridge.com/en/news/273224658.md)